Founded in 2019, Abogen Biosciences is one of the pioneering biotech companies in China to develop mRNA-based therapeutics. The company bears firm belief in the boundless prospects of mRNA science and technology. Upholding this vision, we have established our own proprietary mRNA platform and LNP-based delivery system to open a world of possibilities for creating an unprecedented abundance and diversity of treatments that address unmet medical needs.
Abogen is one of few biotech companies in China that self-developed all of key mRNA platform technologies across mRNA synthesis, delivery and manufacturing. Our technology platform enables us to develop vaccines in line with the fast variation of COVID-19 virus. ARCoV ( Commercial name: AWcorna) is the first approved China-made mRNA vaccine in combating against global pandemic.
At Abogen, we keep exploring new frontiers of mRNA to drive progress in drug discovery landscape. We aim to develop a whole new class of mRNA-based therapeutics with better profile of safety and efficacy in prophylactic vaccines, oncology & immunology and protein replacement.
AccountableWe are dedicated ourselves to patients. With the mission to make scientific breakthrough and deliver innovative treatments, we encourage everyone to be a true leader with the courage to do the right thing, sense of urgency and the commitment to timelines and deliverables.
BoldWe relentlessly focus on finding meaningful breakthroughs and transformative solutions to otherwise untreatable diseases. We are encouraged to challenge the status quo, seek truth with facts and data, fiercely innovate and find the ultimate answers through trials and errors.
Open-mindedThere is no permanent authority in scientific research. By advocating openness and embracing diversity, we create an inclusive working place where unique talents are respected, different sounds heard, and curiosity cherished. We are encouraged to learn from each other and strive to get best out of others.
The human body has incredible potentials, and it just needs the right message of what proteins to synthesize to fight against diseases. As we further advance our technology platform, we believe mRNA will completely transform the way how medicines are made and how diseases are treated.—— Bo Ying, Ph D, Founder, Chairman and CEOBo Ying, Ph.D.Founder, Chairman and CEO